Appendix Cancer Surgery
Surgical Treatment for Appendiceal Cancer
Today's article of interest!
Pal Mentor, Jim, has been cancer free for five years!
The Importance of Walking After Surgery (CRS and HIPEC)
By Jim M, cancer free for five years!
After surgery, get up as soon as your healthcare team recommends and as often as they allow. Generally, your nurses will help you to stand up and walk a few steps the first day after surgery, including while you are still in ICU. You will feel unsteady on your feet, therefore, a nurse will assist you.
During the days following surgery set a goal to walk a little farther every day. Begin with two steps, four steps, out the door of your room, half way down the hospital corridor, and so forth. Gradually you will walk the length of the corridor once/twice/three times! Your IV pole will be your “walking partner!”
Getting out of bed and walking may make a difference in your recovery time. Eventually you will be strong enough to stroll down the corridor without a nursing assistant or family member to accompany you!
Click here for more information about Appendix Cancer Surgery
Questions and Answers for Appendix Cancer Surgery
We've had appendix cancer surgery!
Is surgery necessary?
Why isn't an appendectomy "enough?"
How extensive is appendix cancer treatment surgery?
Appendix Cancer Surgery, HIPEC and Chemotherapy overview
Your surgical oncologist will explain and review all treatment options for appendix cancer. Your treatment plan will depend on your overall health, the type of tumor (pathology), the quantity (mass) size and location of the tumor, and whether the cancer has metastasized.
Treatment for appendix cancer generally includes CRS or cytoreductive surgery with or without systemic chemotherapy and HIPEC.
The purpose of debulking surgery is to remove as much tumor as possible. Debulking surgery often includes the removal of the omentum and the right colon. Additionally, for women, debulking will likely include a hysterectomy, if this was not perfomed previously. Adhesions become more troublesome with any additional debulking surgeries.
Cytoreductive surgery is a detailed, lengthy procedure often requiring ten or more hours.
Tumors are removed and destroyed using a variety of surgical techniques including argon beam coagulator, electro-evaporation, laser, and ultrasonic dissection.
CRS (cytoreductive surgery) consists of the removal of as much mucin and visible tumor as possible, from the abdominal cavity. CRS surgery, refers to the removal of all visible tumors present throughout the peritoneal cavity.
Cytoreductive Surgery includes thorough removal or destruction of all visible tumors throughout the surfaces of the peritoneum. Surgery may include the removal or resection of segments of small and large bowel, gall bladder, liver, omentum, ovaries, pancreas, spleen, stomach and uterus, and may require removing the lining of the peritoneum. Improved results are acheived when the surgeon is able to remove all visible tumor with minimal, or no deposits of residual disease (cancer.) The less residual disease, the better the opportunity for HIPEC to be effective.
Hemicolectomy is a surgical procedure involving the removal of a portion of the colon next to the appendix. This procedure may also include the removal of nearby blood vessels and lymph nodes at the same time.
Peritonectomy refers to stripping the parietal peritoneum and resecting structures at the sites that contain adenomucinosis. A combination of surgical techniques are utilized including organ resection, when necessary and tumor destruction via electro-evaporation and argon beam coagulation.
The peritoneum is the transparent serous membrane lining the cavity of the abdomen.
CRS surgery for Appendix Cancer and Pseudomyxoma Peritonei may include the following:
Removal of the omentum, spleen and gall bladder,
Right hemicolectomy, colectomy, removal of the rectum and sigmoid,
Stripping tumor from the surface of the liver,
Resection of the pancreas,
Gastrectomy (partial or total removal of the stomach)
Stripping the peritoneum from left and right hemidiaphragm;
Pelvic peritonectomy,
Ileostomy,colostomy or urostomy
HIPEC may be included at the conclusion of the cytoreductive surgery for the treatment of pseudomyxoma peritonei and appendix cancer if substantial tumor debulking is accomplished through CRS.
HIPEC may be administered when complete removal of visible tumor (or debulking) is achieved through cytoreductive surgery; it involves perfusion of the peritoneal cavity with chemotherapy heated to approximately 40 degrees Celsius.
HIPEC is administered with the infusion of heated chemotherapy during the last 90 minutes of the CRS procedure. Through HIPEC the surgeon(s) intend to destroy any residual tumor cells that may not have been surgically removed during the actual CRS surgery process.
Although this procedure may initially sound drastic to the newly diagnosed patient, rarely is resection and/or removal of all of these organs is required.
Each patient's case is unique; most patients live productive and healthy lives following surgery!
Learn more about HIPEC
Learn more about preparing for surgery
Learn more about Ostomies
Pal Mentors Help You Prepare for Surgery!
Our Pal Mentors are "veterans" of surgery with Drs. Ahrendt, Bartlett, Esquivel, Goodman, Holtzman, Lambert, Levine, Loggie, Lowy, Mansfield, Moran, Morris, Pingpank, Temple, Sardi, Shen, Stewart, Sugarbaker, Selby and Zeh!
Join our Network and request your own Pal Mentor today!
How are patients selected for appendix cancer surgery?
This question is frequently asked by newly diagnosed patients and “veteran” patients experiencing a “recurrence of disease.”
Why are some patients accepted for CRS or CRS/HIPC while others are not?
Is there any truth to the rumors that surgeons “cherry pick” their patients?
Why isn’t every patient a candidate for surgery?
Surgeons refer to the process of evaluating a surgical candidate as “patient selection.”
Many factors are taken into consideration for patient selection.
The success of CRS and HIPEC may be dependent on the:
patient’s overall general health,
complete removal of all tumor tissue,
location of tumor site(s) and
type of tumor (histology and differentiation.)
The following is a very general explanation of how patients are selected as surgical candidates:
1. Preliminary disease criteria
Patients with metastasis to the peritoneum, aka Peritoneal Carcinomatosis.
Patients with disease contained within the abdomen (without metastasis outside the abdomen)
2. Preliminary general health criteria for patient selection
Good overall heath lacking any major co-morbid conditions*.
Age (some surgeons limit the ages of patients they will accept into surgery)
Mental health (coherence, ability to understand instructions, evidence of chemical dependencies, etc.)
Ability to pay for surgery (adequate health insurance coverage or ability to pay out-of-pocket for medical care)
3. Preliminary review of patient medical history
Medical history including surgical history, if applicable, co-morbid conditions* (ie diabetes, lung or heart disease) current medications (prescribed and OTC) allergies and family history
History of present illness including summary of symptoms
Operative reports of previous surgeries
Pathology reports
Record of previous chemotherapy and radiotherapy treatments, if applicable, including dates and protocols
4. Extent of disease
Evaluation of CT scans to determine PCI (Peritoneal Cancer Index.)
The PCI helps the surgeon to determine the extent, volume and locations of the disease.
Evaluation of tumor block samples from original surgery(ies) if applicable.
Laparoscopy optional
Biopsy optional
Evaluation of tumor markers and associated lab tests
Physical examination of the patient
Learn How to Prepare for Surgery
Dr Paul Sugarbaker Explains Surgical Abbreviations
Dr Paul Sugarbaker Provides List of Abbreviations for Surgery and HIPEC
Dr Paul H Sugarbaker
Thank you to Dr Paul Sugarbaker for providing the PMP Pals' Network with this listing of abbreviations commonly used for the treatment of Appendiceal Cancer.
For additional information see our Appendix Cancer Glossary.
1. CS – Chemosurgery (most general abbreviation includes CRS, HIPEC, EPIC and ABC)
2. HIPEC – Hyperthermic intraperitoneal chemotherapy
3. HIPEC + 5FU – Hyperthermic intraperitoneal chemotherapy plus intravenous 5-fluorouracil
4. HIPEC + IFO – Hyperthermic intraperitoneal chemotherapy plus intravenous ifosfamide
5. EPIC – Early postoperative intraperitoneal chemotherapy usually 5-FU or paclitaxel
6. ABC – Adjuvant bidirectional chemotherapy
7. CRS – Cytoreductive surgery
8. CCRS – Complete cytoreductive surgery
9. PM – Peritoneal metastases (should replace PC)
10. PC – Peritoneal carcinomatosis
11. POC – Perioperative chemotherapy
12. LM – Liver metastases
13. LNM – Lymph node metastases
14. LR – Local-regional
15. IP port – Intraperitoneal port used for ABC
16. Tenckhoff catheter – Temporary catheter used to deliver EPIC
Infection Prevention
Today's Article of Interest
Symptoms and Treatment of Blood Clots, DVTs
What are DVTs?
How do you recognize the symptoms of blood clots?
Why is it necessary to seek immediate care?
How are DVTs treated?
Cancer and Blood Clots: Patients Beware
Source:Richard C Frank, MD
How do you recognize the symptoms of blood clots?
Why is it necessary to seek immediate care?
How are DVTs treated?
Cancer and Blood Clots: Patients Beware
Source:Richard C Frank, MD
Systemic Chemotherapy for Appendix Cancer
Has your physician prescribed chemo for appendix cancer treatment?
Read about a variety of systemic chemotherapies
Getting to the Truth About Cancer Pain!
Laparoscopy: minimally invasive surgery
Laparoscopy surgery includes the use of a thin, narrow, tube shaped instrument inserted into the abdominal wall. Laparoscopy may be used as a diagnostic tool, and has become a surgical option for specific patients, providing a less invasive (and less expensive) alternative to more extensive surgery.
Recuperation from laparoscopy requires less hospitalization due to a faster recovery period, with less trauma and post op pain.
The following articles and abstracts pertaining toappendiceal cancer, mesothelioma, pseudomyxoma peritonei, gastric, liver, ovarian and pancreatic cancer are posted for your reference.
Laparoscopy for Oncological Surgery (this article provides a detailed explanation for patients)
Source: MDAnderson, Houston TX
Laparoscopic Mucin Removal of Pseudomyxoma Peritonei
Source: Dept of OB GYN, Kinko Univ, Osaka Japan, 2009
Minimally Invasive Laparoscopic Surgery
Source: Mercy Medical Center
Minimally Invasive Laparoscopic Surgery, Liver, Pancreas
Source: UCSD, Dr Andrew Lowy, 2009
Laparoscopic CRS and HIPEC Treatment for Peritoneal Mesothelioma
Source: Dr Jesus Esquivel, 2009
Laparoscopic Surgery for the Treatment of Peritoneal Surface Malignancies including Pseudomyxoma Peritonei
Source: Memorial Sloan Kettering, NY
Laparoscopic Surgery for the Treatment of Liver Cancer, Pancreas Cancer
Source: University of Southern California
Laparoscopic Staging for Gastric Cancer
Source: Dr Paul Mansfield, MDACC, Annals of Surgical Oncology, 2001
Laparoscopic Colon Resection
Source: UPMC Koch Cancer Treatment Center
Laparoscopic Surgery for Liver Cancer
Source: Dr David L Bartlett UPMC Koch Cancer Center
Laparoscopic Surgery for Whipple Procedure, Pancreatic
Source: USC Norris Cancer Center
Laparoscopic Surgery, Gastric and Esophageal Cancers
Source: Dr Charles Filipi, Creighton University
Laparoscopic restoration of the colon continuity after Hartmann procedure
Source: Pub Med 2009
Laparoscopic Management of Ovarian Cyst
Source: Springerlink:2008
Laparoscopic Management of Pseudomyxoma Peritonei
Source: Cleveland Clinic 1999
Recuperation from laparoscopy requires less hospitalization due to a faster recovery period, with less trauma and post op pain.
The following articles and abstracts pertaining toappendiceal cancer, mesothelioma, pseudomyxoma peritonei, gastric, liver, ovarian and pancreatic cancer are posted for your reference.
Laparoscopy for Oncological Surgery (this article provides a detailed explanation for patients)
Source: MDAnderson, Houston TX
Laparoscopic Mucin Removal of Pseudomyxoma Peritonei
Source: Dept of OB GYN, Kinko Univ, Osaka Japan, 2009
Minimally Invasive Laparoscopic Surgery
Source: Mercy Medical Center
Minimally Invasive Laparoscopic Surgery, Liver, Pancreas
Source: UCSD, Dr Andrew Lowy, 2009
Laparoscopic CRS and HIPEC Treatment for Peritoneal Mesothelioma
Source: Dr Jesus Esquivel, 2009
Laparoscopic Surgery for the Treatment of Peritoneal Surface Malignancies including Pseudomyxoma Peritonei
Source: Memorial Sloan Kettering, NY
Laparoscopic Surgery for the Treatment of Liver Cancer, Pancreas Cancer
Source: University of Southern California
Laparoscopic Staging for Gastric Cancer
Source: Dr Paul Mansfield, MDACC, Annals of Surgical Oncology, 2001
Laparoscopic Colon Resection
Source: UPMC Koch Cancer Treatment Center
Laparoscopic Surgery for Liver Cancer
Source: Dr David L Bartlett UPMC Koch Cancer Center
Laparoscopic Surgery for Whipple Procedure, Pancreatic
Source: USC Norris Cancer Center
Laparoscopic Surgery, Gastric and Esophageal Cancers
Source: Dr Charles Filipi, Creighton University
Laparoscopic restoration of the colon continuity after Hartmann procedure
Source: Pub Med 2009
Laparoscopic Management of Ovarian Cyst
Source: Springerlink:2008
Laparoscopic Management of Pseudomyxoma Peritonei
Source: Cleveland Clinic 1999
The PMP Pals' Network updates our website 364 days per year with a wide variety of new information to keep you informed about maintaining optimal health!
Whether you seek information about research studies, health insurance, personal mentoring, diet and exercise, new treatment options, and so much more, the PMP Pals' Network is your "go to" place for information!
Visitors to www.pmppals.org are encouraged to discuss publications and information contained herein with their licensed, professional healthcare providers. The information provided on www.pmppals.org is not intended as a replacement for licensed, professional medical or legal advice.
As a volunteer patient advocacy program, representing the needs of patients and their families, the PMP Pals' Network neither solicits, nor receives funding or advertising revenue from cancer treatment centers, pharmaceutical companies, or physicians who treat cancer. We support our program services through subscription dues, gifts from fellow patients and their families, and the hours of time and talents that we donate as volunteers to serve others!
We neither solicit nor receive funds from pharmaceutical companies or healthcare providers, thus maintaining our dedication to serving as patient advocates.
Please respect your fellow patients and caregivers by not copying or cutting and pasting any pages from this website onto yours.
Individuals or organizations who plagiarize this copyrighted website will be prosecuted.
This particular page was last updated on 11.01.11
Copyright 2011 by PMP Pals' Network/Gabriella Graham/All rights reserved.